For more than 30 years it was believed that globin gene domains included only genes encoding globin chains. Here we show that in chickens, the domain of a-globin genes also harbor the non-globin gene TMEM8. It was relocated to the vicinity of the a-globin cluster due to inversion of an $170-kb genomic fragment. Although in humans TMEM8 is preferentially expressed in resting T-lymphocytes, in chickens it acquired an erythroid-specific expression profile and is upregulated upon terminal differentiation of erythroblasts. This correlates with the presence of erythroid-specific regulatory elements in the body of chicken TMEM8, which interact with regulatory elements of the a-globin genes.
INTRODUCTION
Experiments on chromosome painting have demonstrated that chromosomes of different vertebrates are constructed from a number of more or less conserved fragments, which are arranged in different combinations in genomes of various species (1) . This principle of chromosome organization results in the existence of long syntenic regions in the genomes of different organisms. One such region includes the cluster of a-globin genes and genes located upstream of this cluster in different vertebrates (2) . This region of synteny and conserved gene order was initially thought to end right after the cluster of a-globin genes (2) . Later it was found that at least one gene (LUC7L) located downstream of the a-globin gene cluster is also conserved in many vertebrates (3, 4) . In the chicken genome, the LUC7L gene is located $170-kb downstream of the a-globin gene cluster, whereas the TMEM8 gene is located directly downstream of the cluster of a-globin genes. Several orthologous genes present between LUC7L and TMEM8 (RGS11, AXIN1 and MRPL28) are located in inverse order in humans, as compared to chickens. It is thus likely that an $170-kb genomic fragment located downstream of the a-globin cluster is inverted in the chicken genome as compared to the human genome ( Figure 1 ).
The chicken domain of a-globin genes represents a typical example of functional genomic domains, also known as domains with loosely defined borders (5, 6) . It is not quite clear how the specificity of action of regulatory systems in these genomic domains, which frequently contain closely located or even overlapping tissue-specific and housekeeping genes, is achieved or what restricts the action of tissue-specific regulatory elements over long distances (6, 7) . If indeed the downstream area, including most probably the downstream border of the ancestral a-globin gene domain, was disturbed in the chicken genome due to the inversion of a genomic segment, the regulatory system of the domain might also have been disturbed and thus would need to be reestablished de novo. In this work, we have studied whether regulatory elements of the a-globin gene domain influence expression of the TMEM8 gene that was brought into the vicinity of the a-globin gene domain by genomic inversion. In humans, the TMEM8 gene is highly expressed in the placenta, pancreas and lymphocytes, but not in erythroblasts (8) . We have demonstrated that in chickens this gene is preferentially expressed in erythroid cells and is not active in lymphocytes. Furthermore, in chickens, TMEM8 is upregulated upon terminal differentiation of erythroblasts, which does not occur in humans. In accordance with these findings, we have demonstrated that in cultured chicken erythroblasts stimulated to terminal erythroid differentiation, the erythroid-specific downstream enhancer of the a-globin gene domain directly interacts with TMEM8 and hence is involved in regulation of this gene's expression. Finally, an erythroid-specific enhancer co-localizing with a cluster of GATA1 binding sites was identified in one of the introns of the chicken TMEM8 gene. These results suggest that in chickens, a non-globin gene, TMEM8, became incorporated into the functional domain of a-globin genes.
MATERIALS AND METHODS

Cell culture
The avian erythroblastosis virus-transformed chicken erythroblast cell line HD3 [clone A6 of the line LSCC (9) ] and the DT40 lymphoid cell line (CRL-2111, ATCC) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 2% chicken serum and 8% fetal bovine serum (FBS) at 37 C with 5% CO 2 . In the case of DT40 cells, the medium also contained 50 mM b-mercaptoethanol. K562 cells were grown in RPMI 1640 medium containing 10% FBS. Chicken embryonic fibroblasts (CEFs) were isolated from 9-day chicken embryos according to the standard protocol (10) and grown in DMEM supplemented with 8% FBS and 2% chicken serum.
Terminal erythroid differentiation of HD3 cells was induced by incubation at 42 C in a 100% air atmosphere in the presence of 20 mm of iso-H-7 (1-(5-Isoquinolinylsulfonyl)-3-methylpiperazine dihydrochloride (Sigma Aldrich, USA), as previously described (11) . Terminal erythroid differentiation of K562 cells was induced by incubation in the presence of 10 mM sodium butyrate (12) .
Source of biological tissues and cells
All experiments were conducted in accordance with Russian regulations for the protection of experimental animals. Stomach, muscle, spleen, brain, fat, lung, heart, liver and whole blood were taken from 5-month-old female chickens. To separate peripheral blood mononuclear cells and erythrocytes, 2 ml of heparinized blood were diluted with an equal volume of balanced salt solution (GE Healthcare, UK) and layered on 4 ml of Ficoll-Paque PLUS (GE Healthcare, UK). After centrifugation at 4 C for 30 min at 400 g, mononuclear cells remained at the interphase, while erythrocytes and granulocytes were in the pellet. Mononuclear cells were collected and washed three times with balanced salt solution. The pellet containing mainly erythrocytes also was collected and washed with balanced salt solution.
Extraction of RNA and real-time reverse transcriptasepolymerase chain reaction analysis RNA was extracted from cells and tissues using 'Trizol' reagent (Invitrogen, Life Technologies, USA). All RNA samples were further treated with DNase I (Fermentas, Lithuania) to remove residual DNA. RNA (1 mg) was reverse transcribed in a total volume of 20 ml for 1 h at 42 C, using 0.4 mg random hexamer primers and 200 U reverse transcriptase (Fermentas, Lithuania) in the presence of 20 U of ribonuclease inhibitor (Fermentas, Lithuania). The cDNAs obtained were analyzed by real-time polymerase chain reaction (real-time PCR) using the CFX96 real-time PCR detection system (BioRad). A PCR mixture in a volume of 20 ml contained 50 mM Tris-HCl (pH 8.6), 50 mM KCl, 1.5 mM MgCl2, 0.1% Tween-20, 0.5 mM of each primer, 0.25 mM of TaqMan probe (5 0 -FAM dye, inside -BHQ-1 quencher), 0.2 mM of each dNTP, 0.75 U of Hot Start Taq Polymerase (Sibenzyme, Russia) and 25 ng of cDNA template. PCR reactions were performed as follows: initial denaturation for 5 min at 94 C; 60 cycles of 15 s at 94 C, 60 s at 60 C, and then the plate was read. Each PCR was performed in quadruplicate and the corresponding results were averaged. The sequences of the primers and TaqMan probes are available as Supplementary Data (Table S1) 3C analysis 3C analysis was performed as previously described (11, 13) . A random-ligation control was generated using DNA of a bacterial artificial chromosome containing the chicken a-globin gene domain along with the flanking areas (Gallus gallus BAC clone CH261-75C12, CHORI BACPAC Resources Center).
The ligation products were analyzed using real-time PCR with TaqMan probes as described in the previous section. Primers and TaqMan probes for PCR analysis were designed using the DNA sequence of the Gallus gallus BAC clone CH261-75C12 (AC172304, GenBank) and Primer Premier 5 computer software (PRIMER Biosoft International). The sequences of the primers and the TaqMan probes are available as Supplementary Data (Tables S2-S4) .
To take into account the differences in the efficiency of cross-linking/restriction/ligation and in the quantity of DNA in a 3C templates obtained from cells of different types, an internal standard was used (13) . The housekeeping gene ERCC3 situated on another chicken chromosome was chosen as such standard.
Mapping of DNase I hypersensitive sites
DNase I hypersensitive sites (HSSs) were mapped as described (14) . Genomic DNA from DNAse I-treated nuclei was digested with either HindIII or XbaI. After electrophoresis, Southern hybridization with the probe DHS 1 (for DNA digested with Hind III) or DHS 2 (for DNA digested with XbaI) was performed according to standard protocols (15 
Electrophoretic mobility shift assay
The Electrophoretic mobility shift assay (EMSA) assay was performed as previously described (7, 16) . The sequences of test-fragments harboring GATA1-binding sites 1-3 are presented in Figure 8A . A double-stranded DNA fragment (5 0 AGTGGGGGCTGCAGGTGGCTG ATAAAGAGC 3 0 ) harboring a known GATA1 binding site and a double-stranded DNA fragment (5 0 CTCAGT TGATCTTAGGGCTCTCTCTGCCTG 3 0 ), which does not bind GATA1 protein, were used as specific and nonspecific competitors, respectively (along with poly dI/ dC, which was present in all cases).
Transient transfection experiments
The promoter of the HBA2 gene was obtained using PCR amplification of chicken genomic DNA with the following pairs of primers: aD prom dir 5 0 ttagaagcttATGCAGGCT CTTGGCGA 3 0 and aD prom rev 5 0 tactaagcttGGTGGC AGCTGGTGGG 3 0 . The DNA fragment containing a putative enhancer was PCR amplified from the same DNA using the following primers: Enh dir 3 0 CATACTC GAGTGAGTTTATCCAGCCTT 5 0 and Enh rev 5 0 CAT ACTCGAGACACAGATGAATCACCAG 3 0 . The fragments were cloned in an appropriate order (see schemas in Figure 8 ) into the pGL3 vector (Promega, USA). The test fragment was also cloned into the pGL3 promoter vector (Promega, USA) upstream of the SV40 promoter. All manipulations with recombinant DNAs were performed according to standard protocols (15) . Transfection of the luciferase constructs [1 mg of various test constructs + 1 mg of pRLCMV (Promega, USA)] into HD3 and CEF was performed using TurboFect Õ (Fermentas, Lithuania). The assays for luciferase activity were performed using the Dual-Luciferase Õ Reporter Assay System (Promega, USA), according to the manufacturer's instructions.
RESULTS
Chicken TMEM8 gene is preferentially expressed in erythroid cells
The map of the chicken a-globin gene cluster and genes flanking this cluster both upstream and downstream is presented in Figure 2A . To delimit the upstream and downstream boundaries of the erythroid cell-specific gene domain, we have compared transcription profiles of the C16orf35, TMEM8, MPRL28 and AXIN1 genes in erythroid and non-erythroid chicken cells. With this aim, total RNA was isolated from primary chicken fibroblasts (CEFs), cultured chicken lymphoid cells [line DT40 (CRL-2111, ATCC)] and cultured chicken erythroblasts (line HD3, clone A6 of line LSCC) (9,17). The relative representation of the intronic regions from the abovementioned genes in these RNA samples was determined using real-time reverse transcriptase-polymerase chain reaction (real-time RT-PCR) with TaqMan probes.
The results are summarized in Figure 2B . It is evident that, in contrast to the apparent housekeeping genes C16orf35, MPRL28 and AXIN1, the TMEM8 gene (further referred to as cTMEM8 for chicken TMEM8) is transcribed in proliferating HD3 cells more intensively than in CEF and much more intensively than in DT40 cells. Similar differences between the cell lines were also observed when the abundance of cTMEM8 exonic regions in total RNA samples extracted from CEF, DT40 and HD3 cells was analyzed. The HBA1 (a major 'adult' a-type globin gene also known as a A ) mRNA was not at all detected in CEF and DT40 cells. However, in proliferating HD3 cells the steady state level of this mRNA was 10 times higher than the steady-state level of cTMEM8 mRNA ( Figure 2B ). It was reported previously that in humans the TMEM8 gene (further referred to as hTMEM8 for human TMEM8; also known as M83) is highly expressed in resting Tlymphocytes (8) . To check whether this is also the case in chicken, we assayed RNA samples prepared from erythrocytes and peripheral blood mononuclear cells for the presence of cTMEM8 intronic and exonic sequences. The levels of b-actin exonic sequences and HBA1 gene exonic and intronic sequences were also determined. Peripheral blood mononuclear cells were separated from erythrocytes and granulocytes by using centrifugation through Ficoll-Paque PLUS (see 'Materials and Methods' section). The sample of peripheral blood mononuclear cells isolated by this procedure contained mainly peripheral blood lymphocytes (PBLs), contaminated with $5% of erythrocytes, $3% of granulocytes and <1% of platelets, as verified by microscopic analysis. The results of the analysis ( Figure 2C ) demonstrated that cTMEM8 is either not transcribed or transcribed at very low levels (compared to the level of the b-actin gene transcription) in chicken lymphocytes. At the same time, in erythrocytes, the level of cTMEM8 RNA was relatively high. Not surprisingly, the HBA1 gene transcript (both intronic and exonic regions) was detected only in erythrocytes. In the next set of experiments, we studied expression of cTMEM8 in different tissues of adult chickens. RNA samples were isolated from the stomach, muscle, spleen, brain, fat, lung, heart, liver and whole blood. The quantities of cTMEM8 intronic and exonic sequences and b-actin exonic sequences in RNA samples prepared from these tissues were determined using real-time RT-PCR. The results presented in Figure 2D made it possible to conclude that the level of cTMEM8 transcription (as follows from the comparison of the relative abundance of intronic sequences in RNA samples) was at least 350 times higher in whole blood than in any other tissue tested. The level of cTMEM8 exonic sequences in the whole-blood RNA sample was at least 50 times higher than in RNA samples from other tissues ( Figure 2D ). As it was demonstrated in the previous experiment that cTMEM8 was not expressed in lymphocytes, the present data strongly support a conclusion that cTMEM8 is an erythroidspecific gene. It should be mentioned, however, that the erythroid-specificity of cTMEM8 is not as strict as that of the globin genes. For example, a relatively high level of cTMEM8 expression was observed in CEF ( Figure 2A ). This may reflect some special features of embryonic cells. Nevertheless, even in CEF, the level of cTMEM8 expression was at least two times lower than in proliferating HD3 cells. The difference becomes much more significant (more than 10 times) after induction of terminal differentiation in HD3 cells (see the next section).
Expression of cTMEM8 is stimulated upon induction of proliferating HD3 cells to terminal erythroid differentiation AEV-transformed chicken proerythroblasts (line HD3) correspond to chicken hemopoietic cells of the red lineage arrested at early stages of differentiation (9, 17) . They do not express globins, although the a-globin gene domain resides in an active chromatin configuration (18) . After induction of differentiation, HD3 cells stop proliferation and start expression of 'adult' globin genes (11) . To find out if transcription of cTMEM8 is also stimulated upon differentiation of HD3 cells, we analyzed the relative representation of cTMEM8 intronic and exonic sequences in total RNA samples isolated from proliferating and differentiated HD3 cells. The differentiated state of HD3 cells was confirmed by drastic increase of the steady state level of HBA1 mRNA monitored by the analysis of abundance of HBA1 exonic sequences in total RNA samples from proliferating cells and cells induced to differentiation ( Figure 3A ). The transcription of cTMEM8 was also induced approximately five times upon differentiation of HD3 cells ( Figure 3A) . However, the levels of MPRL28 and AXIN1 expression are not changed significantly upon differentiation of HD3 cells. In the next experiment, we checked if expression of hTMEM8 is similarly stimulated upon terminal differentiation of human erythroleukemia cells K562 (12) . Analysis of RNA samples from proliferating and differentiated K562 cells ( Figure 3B ) demonstrated that transcription of hTMEM8 was not induced upon differentiation of K562 cells, although an induction of HBA2 (the human ortholog of the chicken HBA1 gene) was quite obvious. Thus the expression profiles of cTMEM8 and hTMEM8 are basically different.
The cTMEM8 primary transcript is spliced and poly A + RNA encoded by cTMEM8 is accumulated in differentiated HD3 cells
In contrast to humans where both the mRNA and the protein product of the hTMEM8 gene were characterized (8), cTMEM8 was identified as an ORF by bioinformatics methods only (XM_425255, XP_425255). Thus we posed the question of whether the transcript of this gene (ORF) is correctly spliced and whether the mRNA encoded by this gene could be identified by northern blot analysis. Based on the predicted intron-exon structure of cTMEM8 (Ensembl protein coding Gene: ENSGALG00000007471 (UniProtKB/TrEMBL: Q8UWG9_CHICK)), we have designed four pairs of PCR primers located in different exons (see Figure 4A -C). Using these primers for PCR amplification of RT products initiated from random primers on total RNA samples from differentiated HD3 cells, we demonstrated that introns 1, 3, 9 and 11 of cTMEM8 were correctly spliced. We next performed a northern analysis of poly A+ RNA samples isolated from proliferating and differentiated HD3 cells. The cTMEM8-specific probe identified a single band of $5 kb present in both RNA samples ( Figure 4D ). The intensity of this band was, however, much more prominent in the slot loaded with poly A+ RNA from differentiated HD3 cells.
In cultured chicken erythroblasts (line HD3), the cTMEM8 gene directly interacts with the downstream enhancer but not with the upstream LCR-like major regulatory element of the a-globin gene domain
In the next set of experiments, we checked whether the expression of cTMEM8 is controlled by known regulatory elements of the a-globin gene domain. We have previously demonstrated that in differentiated HD3 cells, an activating complex [active chromatin hub (19) ] is assembled that includes the upstream regulatory element (MRE), the À9-Kb erythroid-specific DNase I hypersensitive site (À9 DHS), the upstream CpG island of the a-globin gene domain, the HBA2 gene promoter and the downstream enhancer of the a-globin gene domain (11) . The simplest supposition was that cTMEM8 was also recruited to this chromatin hub. To verify this supposition we performed quantitative 3C analysis (11, 20) . As in the previous study (11) , the spatial organization of the analyzed genomic area in lymphoid (DT40) cells and erythroid cells (proliferating and differentiated HD3 cells) was compared. The BamHI and BglII restriction enzymes were used to cut the area of interest into fragments. Positions of PCR primers and TaqMan probes are shown in Figure 5A . We first used the DNA fragment containing the MRE as an anchor and analyzed the frequency of association of this fragment with all fragments located downstream of the a-globin gene cluster per se, starting from the downstream enhancer. Only association of the MRE with the downstream enhancer in differentiated HD3 cells was detected, which was expected, taking into account the previous data (11) . Neither cTMEM8 nor the DNA fragments flanking cTMEM8 showed increased association frequency with the anchor fragment containing the MRE ( Figure 5B ). Quite different observations were made when the anchor was placed on the DNA fragment containing the À9 DHS. In HD3 cells, in addition to the downstream enhancer, this fragment was preferentially associated with two regions located downstream of the enhancer, namely with the DNA fragment containing the CpG island located upstream of cTMEM8 and the DNA fragment derived from the middle part of cTMEM8. The association frequency of the À9 DHS with the middle part of cTMEM8 was the same in proliferating and differentiated HD3 cells. In contrast, the association frequency of the À9 DHS with the CpG island was 3.5 times more prominent in differentiated HD3 cells than in proliferating HD3 cells. None of these associations was detected in DT40 cells ( Figure 5C ). It should be mentioned that association frequencies of the À9 DHS with the upstream CpG island of the a-globin gene domain and globin gene promoters were not analyzed in this experiment because this analysis was done previously (11) .
When the anchor was placed on the downstream enhancer, a high frequency of association between the CpG island located upstream of cTMEM8 and the middle portion of cTMEM8 was observed in differentiated HD3 cells ( Figure 5D ). In addition, an elevated level of association between the enhancer and the À9 DHS was observed in these cells [in accordance with the previously published results (11) ]. None of the above-mentioned associations was detected in proliferating HD3 and DT40 cells.
Taken together, the results presented in Figure 5C and D argue for a supposition that the À9 DHS is involved in the regulation of cTMEM8 expression in proliferating HD3 cells and that both the À9 DHS and the downstream enhancer of the a-globin gene domain are involved in regulation of cTMEM8 expression in differentiated HD3 cells. The targets of the above regulatory elements are likely located within the 6-kb BamHI-BglII fragment containing a CpG island and the 6-kb BamHI fragment representing the internal part of cTMEM8. To verify the above supposition we have placed the anchor sequentially on each of the two fragments. The results obtained ( Figure 5E and F) demonstrate that in differentiated HD3 cells, these fragments interact with each other and also with the À9 DHS and the downstream enhancer. In accordance with the observations made with the anchor placed on the À9 DHS ( Figure 5C ), in reciprocal experiments we found that the frequency of association of the CpG island with the À9 DHS was much lower in proliferating HD3 cells as compared to the same cells after induction of differentiation ( Figure 5E ). The frequencies of associations of the middle part of the cTMEM8 gene with the À9 DHS were confirmed to be similar in proliferating and differentiated HD3 cells (compare Figure 5C and F) . Neither of the two fragments in this study interacted with promoters of adult globin genes. This suggests that, due to the two alternative spatial configurations of the a-globin gene domain, the À9 DHS and the downstream enhancer may activate either globin genes or the cTMEM8 gene. To increase the resolution of 3C analysis, experiments with the anchor fixed at the downstream enhancer were repeated after digestion of fixed chromatin with MboI. In these experiments, only differentiated HD3 cells were studied. Digestion with MboI allowed us to separate the CpG island from other parts of the cTMEM8 upstream area and also cut the internal part of cTMEM8 into several relatively short fragments (see the scheme in the Figure 6 ). The results of the 3C analysis ( Figure 6 ) made it possible to conclude that the downstream enhancer of the a-globin gene domain interacts with the CpG island per se. As for the body of cTMEM8, the sites of preferential interaction with the downstream enhancer were mapped within introns 3 and 8 of this gene.
DNA fragments from the downstream flanking area of the a-globin gene cluster that interact with the erythroid cell-specific regulatory elements harbor erythroid-specific and permanent DNase I HSSs
To map DNase I HSSs in the downstream flanking region of the a-globin gene cluster, the indirect end-labeling approach (21) was employed. The design of the experiments and the results obtained are shown in Figure 7 . Permeabilized cells (DT40 or proliferating HD3) were treated with increasing amounts of DNase I. After purification, DNA was digested with either the HindIII or the XbaI restriction enzyme and subjected to Southern analysis with probes recognizing the downstream ends of a 14.8-kb HindIII fragment harboring the upstream CpG island of cTMEM8 and a 9.1-kb XbaI fragment harboring virtually all internal portions of cTMEM8 ( Figure  7A ). Analysis of hybridization results ( Figure 7B and C) has permitted us to localize three DHSs in DT40 cells and three DHSs in HD3 cells ( Figure 7D) ; only one appeared common to both cell lines. A very strong erythroid-specific DHS was mapped to the middle of the cTMEM8 ORF.
Identification of an erythroid-specific enhancer element in intron 7 of the cTMEM8 gene Direct interaction of the downstream enhancer of the a-globin gene domain with the CpG island and the body of the cTMEM8 gene suggested that partner regulatory elements might be located within these regions. To investigate this possibility, we first searched for clustered GATA1 sites within the 20-kb genomic fragment that included both the CpG island and the body of the cTMEM8 gene. GATA1 is a transcriptional activator that plays an important role in hematopoiesis (22) . It has been reported previously that a cluster of three GATA1 binding sites present in the a-globin gene domain downstream enhancer is sufficient for activation of transcription driven by globin gene promoters (23) . We performed in silico analysis of the genomic fragment with coordinates 12 735-12 755 (see the map in Figure 5 ) and found a cluster of three GATA1-binding sites (WGATAR) within intron 7 of the cTMEM8 gene ( Figure 8A ). Using a gel retardation assay (16, 24) , we have demonstrated that each of the WGATAR sites present in the above-mentioned cluster indeed binds GATA1 ( Figure 8B ). The $400-bp DNA fragment harboring DNase I HSS and clustered GATA1-binding sites was tested for enhancer activity in transient transfection experiments. With this aim, the fragment was cloned upstream of the firefly luciferase gene driven by the chicken HBA2 gene promoter. This construct, as well as a similar construct without the tested fragment and a construct lacking both the tested fragment and the HBA2 gene promoter, were transfected into HD3 cells and CEF. Subsequent analysis made it possible to conclude that the fragment under study ensured $6-fold stimulation of the HBA2 promoter activity in HD3, but not in CEF ( Figure 8C ). In the next set of experiments, the DNA fragment under study was placed upstream of the firefly luciferase gene driven by the SV40 promoter.
No stimulation of this promoter activity was observed in either HD3 cells or CEF ( Figure 8C ). Therefore, we concluded that the identified enhancer element is erythroid-specific and can activate only erythroid-specific promoters. It is important to mention that the cluster of GATA1 binding sites present in the intron 7 of cTMEM8 is not conserved in evolution. It particular, this cluster is not present in the corresponding region of hTMEM8 ( Figure S1 )
No GATA1 sites were found in the CpG island located upstream to cTMEM8, and the functional significance of this element presently remains unclear.
DISCUSSION
The chicken globin genes were among the first eukaryotic genes cloned and sequenced (25) (26) (27) (28) (29) . Since this time, chicken globin gene domains have become popular models to study the regulation of gene expression (6) . The same is true for other vertebrate globin gene domains (30) (31) (32) (33) (34) . During the last 25 years, the models describing regulation of globin genes expression have become more and more complex. Yet one piece of knowledge about vertebrate globin gene domains had not changed during these years: it remained a common opinion that these erythroid-specific gene domains contained only genes encoding globin chains. Here, we show that, in chickens, the a-globin gene domain also contains cTMEM8, an erythroid cell-specific gene, inducible upon terminal erythroid differentiation, which does not encode a globin chain. This gene is likely to fall into the downstream region of the a-globin gene domain because of an inversion of a relatively small chromosomal segment (see the 'Introduction' section and Figure 1) . In a prototypical a-globin cluster derived from multispecies comparisons, the place of cTMEM8 is occupied by LUC7L (35), which is located in the downstream flanking region of the a-globin gene domain in genomes of many modern animals (3, 4) . TMEM8 (aliases: M83, TMEM6) is a highly conserved gene that encodes a transmembrane protein with five membrane-spanning domains (8) . The protein product of this gene has been characterized only in humans (UniProtKB: Q9HCN3). It was proposed that its biological role is related to the T-cell resting status, as it was highly expressed in resting T lymphocytes and downregulated by cell activation (8) . Although the level of hTMEM8 transcription in whole-blood samples was found to be relatively high (GNF Symatlas data; http:// symatlas.gnf.org), this is likely due to the intensive transcription of hTMEM8 in resting T lymphocytes present in the whole blood samples (8) . hTMEM8 RNA was not detected in circulating human blood reticulocytes (36) (see also NIDDK Hembase at http:// hembase.niddk.nih.gov). In accordance with these data, we have shown that hTMEM8 is not upregulated upon terminal erythroid differentiation of human K562 cells. In contrast, expression of cTMEM8 was upregulated upon terminal erythroid differentiation of chicken HD3 cells. Furthermore, the transcript of cTMEM8 was present in circulating erythrocytes purified from the blood of adult birds. The level of cTMEM8 mRNA in circulating erythrocytes was comparable with b-actin mRNA levels and constituted about 0.4% of the HBA1 mRNA level. On the other hand, cTMEM8 was virtually not expressed in chicken lymphocytes. In cultured chicken B lymphocytes (cells DT40), the level of cTMEM8 mRNA was also very low. Based on these observations, we concluded that, after relocation in close proximity to the a-globin gene cluster, cTMEM8 came under the control of erythroid-specific regulatory elements and acquired an erythroid cell-specific expression profile. The genes MPRL28 and AXIN1, which are located further downstream of the a-globin gene cluster, did not show any elevated expression in HD3 cells (as compared to DT40 and CEF) and were not upregulated upon terminal erythroid differentiation of HD3 cells. The relocation of cTMEM8 to the proximity of the a-globin gene domain could hardly automatically make this gene erythroidspecific. Indeed, domains of vertebrate a-globin genes belong to the class of functionally determined gene domains (5, 6) . These tissue-specific gene domains are located in gene-rich areas that also harbor widely expressed housekeeping genes (5, 6) . One of characteristic features of a-globin gene domains of all vertebrates is that their profile of sensitivity to DNase I does not depend on cell lineage (18, 37) . In addition, in all vertebrates studied, the MRE of the a-globin gene domain is located in one of introns of the housekeeping gene C16orf35, located upstream of the a-globin gene cluster (2, 38, 39) . Celllinage-specific regulation of a-globin gene expression likely depends on the specific interactions of regulatory elements with the promoters of globin genes (11, 40) .
In humans, the a-globin gene domain is flanked downstream by the widely expressed (apparently housekeeping) gene LUC7L (3, 41) . This gene is located closer to the a-globin cluster in human chromosome 16 (8.7 kb between the LUC7L and the HBQ1) than the cTMEM8 gene in chicken chromosome 14 (12 kb between cTMEM8 and HBA1) and yet it does not seem to be controlled by erythroid-specific enhancers. Thus, location of a gene in close proximity to the a-globin gene cluster is not sufficient to put this gene under the control of globin gene regulatory elements. The presence of erythroid-specific DHSs within the body of cTMEM8 and in the upstream flanking region of this gene suggests that during evolution, cTMEM8 acquired erythroid-specific regulatory elements that might be functionally relevant themselves, but even more importantly, assure incorporation of cTMEM8 into the regulatory network of the a-globin gene domain. One of these regulatory elements is an erythroid-specific enhancer, which we have found in the body of cTMEM8. Similar to the downstream enhancer of the a-globin gene domain (23) , this additional enhancer likely depends on the GATA1 factor. Incorporation of the cTMEM8 gene into the regulatory cascade of the a-globin gene domain constitutes an interesting example of the expansion of a functional genomic domain. Further studies of mechanisms regulating cTMEM8 expression may provide new insights into how functional genomic domains are organized.
Using 3C analysis, we have demonstrated that two previously identified regulatory elements of the chicken a-globin gene domain interact with cTMEM8 and the upstream flanking region of this gene in terminally differentiated HD3 cells. These regions are the downstream enhancer of the a-globin gene domain (see the scheme in Figure 5 ) and the as-yet uncharacterized regulatory element that co-localizes with the erythroid-specific À9 DHS.
Taking into account the stimulation of cTMEM8 expression upon terminal erythroid differentiation of HD3 cells, one could expect that expression of this gene is controlled by regulatory elements of the a-globin gene domain. The unexpected finding was that the configurations of active chromatin hubs regulating expression of adult a-globin genes and cTMEM8 were strictly different ( Figure 9 ). The alternative chromatin hubs share two regulatory elements (the À9 DHS and the downstream enhancer) while the other players are different. To this end, it may be of interest that neither the À9 DHS nor the downstream enhancer of the chicken a-globin gene domain is present among the previously identified multispecies conserved sequences (35) . In other words, these regulatory elements are unique to chickens. It is possible that peculiar properties of the chicken a-globin gene domain regulatory system, especially the existence of the downstream enhancer element, made it possible for this system to redirect the expression profile of cTMEM8, making this gene erythroid-specific. It may be of interest that the À9 DHS and the downstream enhancer do not interact with the HBA1 gene promoter in proliferating HD3 cells. They are recruited to the aglobin gene domain active chromatin hub only upon induction of HD3 cells to terminal erythroid differentiation. Here we show that the same elements participate in organization of the cTMEM8-activating complex. In this regard, it is important to note that chicken a-globin genes are not imprinted. They do not show the asynchronous replication pattern typical of imprinted genes (18) , and transcription of both alleles can be detected by hybridization in situ (42, 43) . Thus, on each chromosome the À9 DHS and the downstream enhancer should shuttle between two chromatin hubs as predicted by the 'flipflop' model (44, 45) . This model was proposed to explain the ability of the b-globin gene domain LCR to activate transcription of several genes that appeared to be transcribed simultaneously. Although this model was never disproved, it was almost forgotten after the discovery of active chromatin hubs (19, 31, (46) (47) (48) , as the assembly of an enhancer and several promoters into a single active chromatin hub suggests a more simple explanation for the ability of an enhancer to simultaneously activate several promoters. Our data suggest that the two models are not mutually exclusive and that chromatin hubs should be regarded as dynamic rather than static.
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